Therapeutic Performance

As a cyclopyrrolone derivative, Zopisign 10mg enhances the signaling of the GABA-A receptors within the central nervous system. This pharmacological action induces sedation, reduces anxiety, and facilitates a rapid transition into deep sleep. The 10mg variant offers a higher concentration of active Zopiclone for targeted efficacy.

Safety & Usage Guidelines

To ensure maximum therapeutic benefit and patient safety, please adhere to the following clinical guidelines:

• Administration: Take one 10mg tablet immediately before retiring for the night.
• Duration: Recommended for short-term use (usually 7-14 days).
• Contraindications: Do not use if you have severe respiratory insufficiency or sleep apnea.
• Interactions: Avoid alcohol consumption as it significantly increases the sedative effect.